Abvitro has raised $745,000 in venture capital, the company disclosed in a new regulatory filing. One investor participated in the round, which was part of an overall $3M offering.
AbVitro is a George Church company founded in 2010. molecular geneticist. He is currently Professor of Genetics at Harvard Medical School, Professor of Health Sciences and Technology at Harvard and MIT, and a core faculty member at the Wyss Institute for Biologically Inspired Engineering at Harvard University. The firm is a portfolio company of BioInnovation, a local incubator.